Cordis Global Medical Technology
ETL4642AU
Cordis Global Medical Technology ETL4642AU Strategy
The Fund follows a fundamental long-only active strategy. Cordis runs a high conviction actively managed specialised portfolio, limited to between 20-40 stocks selected from the medical technology sub-sector of listed global healthcare companies.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,550.30 | 36.60 | -0.43% |
CAC 40 | 7,409.57 | 11.37 | -0.15% |
DAX 40 | 20,405.92 | 20.35 | -0.10% |
Dow JONES (US) | 43,828.06 | 86.06 | -0.20% |
FTSE 100 | 8,300.33 | 11.43 | -0.14% |
HKSE | 19,971.24 | 425.81 | -2.09% |
NASDAQ | 19,926.72 | 23.88 | 0.12% |
Nikkei 225 | 39,470.44 | 378.70 | -0.95% |
NZX 50 Index | 12,754.26 | 61.54 | 0.48% |
S&P 500 | 6,051.09 | 0.16 | -0.00% |
S&P/ASX 200 | 8,296.00 | 34.30 | -0.41% |
SSE Composite Index | 3,391.88 | 69.62 | -2.01% |